Valuation (33%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 11.12 | N/A |
PEG Ratio (TTM) | -0.65 | N/A |
P/S Ratio (TTM) | 37.17 | N/A |
P/B Ratio (TTM) | 0.93 | N/A |
P/FCF Ratio (TTM) | N/A | N/A |
Price to 5YR AVG Earnings Ratio | 166.38 | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (50%) |
Company | Industry |
---|---|---|
ROA (TTM) | 8.27% | N/A |
ROE (TTM) | 8.41% | N/A |
Net Profit Margin (TTM) | 334.19% | N/A |
ROIC 5YR AVG | -2.95% | N/A |
Growth (38%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 18.93% | -12.85% | -0.81% |
Revenue | 17.35% | -36.71% | 13.17% |
Net Income | 20.39% | -32.64% | 21.44% |
Cash Flow | N/A | N/A | N/A |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | N/A | N/A |
Quick Ratio (TTM) | N/A | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | 440,907.04 | N/A |
Piotroski F-Score | 5 | N/A |
Altman Z-Score | 53.91 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | -25.79% | N/A |